Taiyen Biotech Co Ltd (1737) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Taiyen Biotech Co Ltd (1737) has a cash flow conversion efficiency ratio of 0.015x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$99.80 Million ≈ $3.14 Million USD) by net assets (NT$6.71 Billion ≈ $211.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Taiyen Biotech Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
Taiyen Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Taiyen Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Taiyen Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Taiyen Biotech Co Ltd ranked by their cash flow conversion efficiency. Explore 1737 cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Electreon Wireless Ltd
TA:ELWS
|
-0.154x |
|
China Dongxiang (Group) Co. Ltd
F:4C1
|
0.001x |
|
Brockhaus Capital Management AG
F:BKHT
|
0.059x |
|
Pioneer Municipal High Income Opportunities Fund Inc
NYSE:MIO
|
-1.549x |
|
Nextgreen Global Bhd
KLSE:7241
|
0.093x |
|
Sunjuice Holdings Co Ltd
TW:1256
|
0.020x |
|
Wei Chuan Foods Corp
TW:1201
|
0.000x |
|
Columbus A/S
CO:COLUM
|
0.010x |
Annual Cash Flow Conversion Efficiency for Taiyen Biotech Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Taiyen Biotech Co Ltd from 2003 to 2025. View 1737 share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$6.81 Billion ≈ $214.67 Million |
NT$473.77 Million ≈ $14.93 Million |
0.070x | -29.77% |
| 2024-12-31 | NT$6.67 Billion ≈ $210.07 Million |
NT$660.12 Million ≈ $20.80 Million |
0.099x | +42.64% |
| 2023-12-31 | NT$6.55 Billion ≈ $206.32 Million |
NT$454.54 Million ≈ $14.32 Million |
0.069x | -20.37% |
| 2022-12-31 | NT$6.66 Billion ≈ $209.89 Million |
NT$580.69 Million ≈ $18.29 Million |
0.087x | -5.39% |
| 2021-12-31 | NT$6.51 Billion ≈ $205.21 Million |
NT$600.08 Million ≈ $18.91 Million |
0.092x | +72.78% |
| 2020-12-31 | NT$6.36 Billion ≈ $200.51 Million |
NT$339.36 Million ≈ $10.69 Million |
0.053x | -0.82% |
| 2019-12-31 | NT$6.15 Billion ≈ $193.85 Million |
NT$330.81 Million ≈ $10.42 Million |
0.054x | -26.43% |
| 2018-12-31 | NT$6.16 Billion ≈ $193.93 Million |
NT$449.83 Million ≈ $14.17 Million |
0.073x | -27.65% |
| 2017-12-31 | NT$6.02 Billion ≈ $189.62 Million |
NT$607.87 Million ≈ $19.15 Million |
0.101x | +6.43% |
| 2016-12-31 | NT$5.99 Billion ≈ $188.60 Million |
NT$568.06 Million ≈ $17.90 Million |
0.095x | +44.86% |
| 2015-12-31 | NT$5.86 Billion ≈ $184.65 Million |
NT$383.93 Million ≈ $12.10 Million |
0.066x | +2.83% |
| 2014-12-31 | NT$5.82 Billion ≈ $183.52 Million |
NT$371.06 Million ≈ $11.69 Million |
0.064x | +79.77% |
| 2013-12-31 | NT$5.73 Billion ≈ $180.67 Million |
NT$203.21 Million ≈ $6.40 Million |
0.035x | +49.72% |
| 2012-12-31 | NT$6.53 Billion ≈ $205.60 Million |
NT$154.46 Million ≈ $4.87 Million |
0.024x | -36.43% |
| 2011-12-31 | NT$6.61 Billion ≈ $208.23 Million |
NT$246.09 Million ≈ $7.75 Million |
0.037x | -18.56% |
| 2010-12-31 | NT$6.58 Billion ≈ $207.34 Million |
NT$300.89 Million ≈ $9.48 Million |
0.046x | -16.13% |
| 2009-12-31 | NT$6.57 Billion ≈ $206.92 Million |
NT$358.02 Million ≈ $11.28 Million |
0.055x | -16.99% |
| 2008-12-31 | NT$6.36 Billion ≈ $200.31 Million |
NT$417.51 Million ≈ $13.15 Million |
0.066x | +35.05% |
| 2007-12-31 | NT$6.63 Billion ≈ $208.94 Million |
NT$322.49 Million ≈ $10.16 Million |
0.049x | -26.86% |
| 2006-12-31 | NT$6.96 Billion ≈ $219.34 Million |
NT$462.88 Million ≈ $14.58 Million |
0.066x | -20.34% |
| 2005-12-31 | NT$6.90 Billion ≈ $217.39 Million |
NT$575.91 Million ≈ $18.14 Million |
0.083x | -76.90% |
| 2004-12-31 | NT$7.85 Billion ≈ $247.21 Million |
NT$2.84 Billion ≈ $89.32 Million |
0.361x | -22.55% |
| 2003-12-31 | NT$7.33 Billion ≈ $230.91 Million |
NT$3.42 Billion ≈ $107.73 Million |
0.467x | -- |
About Taiyen Biotech Co Ltd
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers seawater chemicals; toothpaste, mouthwashes, and eyeglass solutions; beverages; bottled water; medical supplies; food and food additives; beauty, skincare, and cleaning products; and salt products; as well as health food and health products. The company was founded in 1952 and is … Read more